Recent news on Phentolamine Mesylate

Illumina Shuttering Connecticut Plant, Relocating 50 Employees  -  Apr 15, 2007
San Diego Business Journal,The active ingredient in NV-101 is phentolamine mesylate, which has been used for more than 50 years in other medical indications at significantly higher

Novalar Pharmaceuticals submits NDA for dental anesthetic reversal ...  -  Apr 12, 2007
News-Medical.net,Phentolamine mesylate (a vasodilator), the active ingredient in the investigational agent NV-101, has been approved and in use in specific medical

NOVALAR Presents Results From Successful Studies Of Anesthetic ...  -  Mar 21, 2007
Medical News Today (press release),Phentolamine mesylate (a vasodilator), the active ingredient in the investigational agent NV-101, has been approved and in use in specific medical

Senetek PLC Announces Clinical Update on Invicorp(R)  -  Mar 1, 2007
Drug Newswire (press release),Invicorp(R) is a patented injectable combination of phentolamine mesylate and vasoactive intestinal polypeptide. Clinical data indicate that the efficacy

NOVALAR's Positive Phase 2 Pediatric Study Results Support Recent ...  -  Nov 15, 2006
Drug Newswire (press release),Phentolamine mesylate (a vasodilator), the active ingredient in the investigational agent NV-101, has been approved and in use in specific medical



Senetek Licenses Invicorp(R) Erectile Dysfunction Treatment to ...  Feb 21, 2006
Invicorp(R) and the erectile dysfunction market Invicorp(R) is Senetek's patented injectable combination of phentolamine mesylate and vasoactive intestinal ... - PR Newswire,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional